Licensed Rights and Other Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2025

Licensed Rights and Other Intangible Assets [Abstract]

Schedule of License Rights and Other Intangible Assets, Net

The following provides information about our license rights and other intangible assets, net as of June 30, 2025 and December 31, 2024 (in thousands):

	June 30, 2025						December 31, 2024
	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Intangible assets subject to amortization:
Hormone therapy drug patents	$	5,767	$	2,248	$	3,519	$	5,766	$	2,058	$	3,708
Hormone therapy drug patents applied and pending approval		215		—		215		304		—		304
Intangible assets subject to amortization		5,982		2,248		3,734		6,070		2,058		4,012
Intangible assets not subject to amortization:
Trademarks/trade name rights		309		—		309		309		—		309
License rights and other intangible assets, net	$	6,291	$	2,248	$	4,043	$	6,379	$	2,058	$	4,321

Schedule of Intangible Assets Subject to Amortization

Our intangible assets subject to amortization are expected to be amortized as follows (in thousands):

Year ending December 31,
2025	$	289
2026		384
2027		384
2028		385
2029		384
Thereafter		1,693
Total	$	3,519